Catalyst Wire Dossier Catalyst Wire Dossier

CM336 Injection

CM336 · Keymed Biosciences Co. Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CM336 Injection, covering 2025-11-26 to 2025-11-26. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating the Efficacy and Safety of CM336 Injection in the Treatment of Light-Chain Amyloidosis [Phase 2]

See pricing